Skip to main content
SpringerLink
Log in

Mycophenolatmofetil vs. Azathioprin bei ANCA-assoziierten Vaskulitiden

Die IMPROVE-Studie

Mycophenolate mofetil versus azathioprin for anti-neutrophil cytoplasmic autoantibody associated vasculitis

The IMPROVE study

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Appel GB, Contreras G, Dooley MA et al (2009) Aspreva Lupus Management Study Group Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103–1112

    Article  CAS  PubMed  Google Scholar 

  2. European Mycophenolate Mofetil Cooperative Study Group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321–1325

    Google Scholar 

  3. Jones RB, Tervaert JW, Hauser T et al (2010) for the European Vasculitis Study Group Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211–220

    Article  CAS  PubMed  Google Scholar 

  4. Stone JH, Merkel PA, Spiera R et al (2010) for the RAVE-ITN Research Group Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 15:221–232

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik Kinderheilkunde I, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 430, 69120, Heidelberg, Deutschland

    B. Tönshoff

Authors
  1. B. Tönshoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Tönshoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tönshoff, B. Mycophenolatmofetil vs. Azathioprin bei ANCA-assoziierten Vaskulitiden. Nephrologe 6, 62–63 (2011). https://doi.org/10.1007/s11560-010-0503-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-010-0503-5

Search

Navigation